Harbour Investments, Inc. Halozyme Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $5,914 - $10,026	-180 Reduced 20.0%	720 $27,000
Q4 2022 Feb 15, 2023	BUY	$40.06 - $59.44 $36,054 - $53,496	900 New	900 $51,000
Q4 2021 Feb 16, 2022	SELL	$31.82 - $40.75 $63 - $81	-2 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $9,309 - $11,233	-242 Reduced 99.18%	2 $0
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $1,475 - $1,949	38 Added 18.45%	244 $11,000
Q1 2021 Aug 17, 2021	BUY	$39.51 - $51.45 $8,139 - $10,598	206 New	206 $9,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.